GGT1 and neoplasm: Moreover, high pre-therapeutic GGT serum levels was associated with the advanced tumor stage and could serve as an independent prognostic marker for the worse survival in patients with epithelial ovarian cancer [11], pancreatic cancer [12] and endometrial cancer [13].